PRODUCT
Summary
SPG11 peptide is used for blocking the activity of SPG11 antibody (catalog number GTX31970).
APPLICATION
Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
Assay dependent |
Not tested in other applications.
PROPERTIES
Form
Liquid
Buffer
PBS, 0.1% BSA
Preservative
0.02% Sodium azide
Storage
Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.
Concentration
200 μg/ml (Please refer to the vial label for the specific concentration.)
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
Spg11, Spatacsin Vesicle Trafficking Associated , Als5 , Cmt2X , Kiaa1840 , Spg11
Background
The protein encoded by this gene is a potential transmembrane protein that is phosphorylated upon DNA damage. Defects in this gene are a cause of spastic paraplegia type 11 (SPG11). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]
Research Area
REFERENCE
There are currently no references for SPG11 blocking peptide (GTX31970-PEP). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for SPG11 blocking peptide (GTX31970-PEP). Be the first to share your experience with this product.